Procalcitonin Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$7500
Buy Report View Sample

Published: October 26, 2023 Report Code: GDME781MM-ST

Select Item

Procalcitonin Tests Market Overview

The procalcitonin tests market size was $557.2 million in 2023. Factors such as the surging burden of sepsis worldwide, rising public awareness, and increased use in antibiotic stewardship programs will drive the market growth at a CAGR of more than 1% during 2023-2033.

Procalcitonin (PCT) Tests are carried out to measure PCT production to diagnose and monitor sepsis. When sepsis occurs, primarily due to bacterial infection, PCT, a peptide precursor of the hormone calcitonin peptide, increases in response to a pro-inflammatory stimulus.

Procalcitonin Tests Market Outlook 2023-2033 ($ Million)

Procalcitonin Tests Market Outlook 2023-2033 ($ Million)

Buy the Full Report for More Insights on the Procalcitonin Tests Market Forecast,
Download a Free Sample Report

The procalcitonin tests market research report identifies quantitative market trends within drug delivery devices therapeutic areas. The report offers regional quantitative and qualitative data, highlighting the sales in major markets. The model also covers in detail the effects of COVID-19 on the procalcitonin tests market for 2020 and beyond. Furthermore, the report provides procalcitonin tests market share by company that will help in identifying untapped market opportunities.

Market Size (2023) $557.2 million
CAGR (2023-2033) >1%
Historic Period 2015-2022
Forecast Period 2023-2033
Key Segments ·        Procalcitonin Enzyme Immunoassay Tests

·        Procalcitonin Other Tests
Key Regions ·        Asia-Pacific

·        Europe

·        Middle East and Africa

·        North America

·        South America
Key Companies ·        Thermo Fisher Scientific Inc

·        F. Hoffmann-La Roche Ltd

·        bioMerieux SA

·        Bio-Rad Laboratories Inc

·        Beckman Coulter Inc + Radiometer Medical ApS
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Procalcitonin Tests Market Segments

The key segments in the procalcitonin tests market are procalcitonin enzyme immunoassay tests and procalcitonin other tests. In 2023, the procalcitonin enzyme immunoassay tests segment dominated the market. The chemiluminescence enzyme immunoassay (CLEIA) is the predominant method employed for detecting procalcitonin (PCT) as an analyte in patient samples.

The chemiluminescence enzyme immunoassay (CLEIA) is the predominant method employed for detecting procalcitonin (PCT) as an analyte in patient samples. Procalcitonin in a patient sample is bound by separate antibodies, one for capture and one for indirect detection.

Procalcitonin Tests Market Analysis by Segments, 2023 (%)

Procalcitonin Tests Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment-Wise Insights into the Procalcitonin Tests Market
Download a Free Sample Report

Procalcitonin Tests Market Segmentation by Regions

The key regions in the procalcitonin tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South America. In 2023, North America held the largest procalcitonin tests market share. The use of procalcitonin testing for sepsis management is highest in the US. This also serves as a major hub for sepsis-related clinical studies.

Compared to regions that accept CE mark in vitro diagnostics, the majority of the North American market lacks exposure to point-of-care PCT tests and testing platforms. Sufficient healthcare expenditure enables the use of automated immunoassay testing. Higher adoption of immunoassay platforms from high market share companies streamlines this process. The use of automated immunoassay testing decreases reliance on qualitative or semi-quantitative lateral flow assays. These assays are commonly used in other regions of the world.

Procalcitonin Tests Market Analysis by Regions, 2023 (%)

Procalcitonin Tests Market Analysis by Regions, 2023 (%)

Buy the Full Report for more Regional Insights into the Procalcitonin Tests Market

Download a Free Sample Report

Procalcitonin Tests Market – Competitive Landscape

In 2023, bioMerieux procalcitonin tests’ market share was the highest.

The major players in the procalcitonin tests market are:

  • Thermo Fisher Scientific Inc.
  • Hoffmann-La Roche Ltd
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Beckman Coulter Inc + Radiometer Medical ApS

Recent developments in PCT testing have often centered on the development and distribution of point-of-care tests and platforms, including devices aimed at ambulatory or field use.

Companies are adopting a comprehensive approach to sepsis management. This approach includes supporting PCT test sales with related products. For blood cultures, companies offer items as part of this approach. Molecular tests for pathogen detection are another component.

Procalcitonin Tests Market Analysis by Companies, 2023 (%)

Procalcitonin Tests Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Company-Wise Insights into the Procalcitonin Tests Market Companies
Download a Free Sample Report

Procalcitonin Tests Market Dynamics

Trends: The key factors positively impacting the procalcitonin tests market growth are the increasing burden of sepsis worldwide and rising public awareness. Also, the increased use of antibiotic stewardship programs will support market growth.

Future Outlook: PCT testing will find growth opportunities in low and middle-income countries wherein the burden of sepsis is highest. Point-of-care (POC) offerings including lateral flow immunoassays or mobile testing platforms may play a key role in driving further adoption of PCT testing for these growth markets.

Purchase the Complete Report for Additional Insights on the Procalcitonin Tests Market Dynamics,

Download a Free Sample Report

Segments Covered in the Report

Procalcitonin Tests Segment Outlook (Value, $ Million, 2015-2033)

  • Procalcitonin Enzyme Immunoassay Tests
  • Procalcitonin Other Tests

Procalcitonin Tests Regional Outlook (Value, $ Million, 2015-2033)

  • Asia-Pacific
  • Europe
  • Middle East and Africa
  • North America
  • South America

Key Inclusions

  • The procalcitonin tests market research report includes an insightful review of the key industry trends.
  • The procalcitonin tests market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
  • The report also includes market-level data on units, average selling prices, and market values.

Regional, Country, and Global Procalcitonin Tests Market Insights:

  • The procalcitonin tests market share report offers qualitative insights on global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • Procalcitonin tests market SWOT analysis.
  • The report provides trends and procalcitonin tests market competitive dynamics.

Buy the Full Report for More Insights on the Procalcitonin Tests Market Share,

Download a Free Sample Report

Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.

  • Country-specific overview of the healthcare system.
  • Country-specific reimbursement policies.
  • Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. In addition, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.

Companies covered: Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, DiaSorin SpA, bioMerieux SA, Bio-Rad Laboratories Inc, Siemens AG, Quidelortho Corp and Diazyme Laboratories Inc, and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

  • Extensive coverage of the procalcitonin tests market under development.

  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of the procalcitonin tests market and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Understand the COVID-19 impact on procalcitonin tests.

  • Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.

  • Develop business strategies by understanding the trends shaping and driving procalcitonin tests.

  • Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.

  • Formulate effective sales and marketing strategies with a detailed evaluation of procalcitonin tests market share by company. Identify strong competitors and create winning strategies to stand out in the global procalcitonin tests market.

  • Track regional procalcitonin tests market sales as well as country-specific transactions from 2015-2033.

  • Organize your sales and marketing efforts by identifying the global procalcitonin tests market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.

Frequently asked questions

Procalcitonin Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 standard reports
Currency USD
$7,500

Can be used by individual purchaser only

Most Popular
$15,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$22,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Procalcitonin Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Procalcitonin Automated Tests reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Procalcitonin Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 in real time.

  • Access a live Procalcitonin Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more